Skip to main content

Table 2 18F-FDG PET/CT parameters between patients with pCR-T and non-pCR-T

From: Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma

Parameters pCR-T (n = 15) non-pCR-T (n = 29) P value
Mean (IQR)
SUVmax-Tpre 20.76(16.82,25.63) 19.94(16.82,25.13) 0.78
MTV-Tpre 18.06(10.95,36.03) 22.44(14.21,29.58) 0.59
TLG-Tpre 173.42(64.96,339.75) 196.60(116.30,270.60) 0.59
SUVmax-Tpost 4.19(3.28,4.73) 5.65(3.99,8.76) 0.02
MTV-Tpost 2.28(1.15,3.55) 5.23(2.94,6.89) 0.00
TLG-Tpost 6.97(3.74,11.62) 17.13(9.09,28.30) 0.00
ΔSUVmax-T  − 0.80(− 0.76, − 0.85)  − 0.70(− 0.58, − 0.79) 0.01
ΔMTV-T  − 0.90(− 0.66, − 0.95)  − 0.77(− 0.63, − 0.86) 0.04
ΔTLG-T  − 0.96(− 0.81, − 0.99)  − 0.89(− 0.87, − 0.95) 0.07
  1. P values less than 0.05 are indicated in bold italics
  2. 18F-FDG-PET/CT 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography; pCR-T complete response of primary tumor; SUVmax maximum standard uptake value; MTV metabolic tumor volume; TLG total lesion glycolysis